Prevalence of CYP2C9 and VKORC1 mutation in patients with valvular heart disease in Northern Thailand
Background: Warfarin has been widely used for the prevention and treatment of thromboembolism. Warfarin therapy depends on interaction between physiological, environmental, and genetic factors. Vitamin K epoxide reductase (VKORC1) and cytochrome P450 2C9 (CYP2C9) enzyme conjointly determine the warf...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
2014
|
| Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-77249097871&partnerID=40&md5=7f6375b1802deaebdac9ea6903382c87 http://www.ncbi.nlm.nih.gov/pubmed/20043560 http://cmuir.cmu.ac.th/handle/6653943832/765 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Chiang Mai University |
| Language: | English |